Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesLiabilities and Shareholders EquityPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Groove Botanicals (GRVE) Common Equity (2016 - 2025)

Groove Botanicals' Common Equity history spans 7 years, with the latest figure at -$1.0 million for Q1 2017.

  • On a quarterly basis, Common Equity fell 82.61% to -$1.0 million in Q1 2017 year-over-year; TTM through Mar 2017 was -$1.0 million, a 82.61% decrease, with the full-year FY2017 number at -$1.0 million, down 82.61% from a year prior.
  • Common Equity hit -$1.0 million in Q1 2017 for Groove Botanicals, down from -$921023.0 in the prior quarter.
  • Over the last five years, Common Equity for GRVE hit a ceiling of $1.9 million in Q2 2015 and a floor of -$1.0 million in Q1 2017.
  • Historically, Common Equity has averaged $543218.8 across 5 years, with a median of $523368.0 in 2013.
  • Biggest five-year swings in Common Equity: soared 139351.49% in 2015 and later plummeted 149.04% in 2016.
  • Tracing GRVE's Common Equity over 5 years: stood at $407805.0 in 2013, then skyrocketed by 233.96% to $1.4 million in 2014, then skyrocketed by 37.91% to $1.9 million in 2015, then plummeted by 149.04% to -$921023.0 in 2016, then decreased by 8.61% to -$1.0 million in 2017.
  • Business Quant data shows Common Equity for GRVE at -$1.0 million in Q1 2017, -$921023.0 in Q4 2016, and -$720700.0 in Q3 2016.